News and Announcements
Ripple Down: A system that enables Physicians to make accurate, informed diagnosis’s in a timely manner
- Published November 08, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Health organisations and physicians are under increasing pressure to provide better patient care in a timely manner.
Ripple Down enables physicians to make accurate, well-informed diagnosis’s, regardless of the time, data and expertise available.
The system listens to all the data collected by a health organisation, health experts, interpret the organisations knowledge and apply their expertise by rules which teach Ripple Down how to automatically interpret symptoms and make accurate diagnosis.
Ripple Down has the ability to enhance clinical performance and can aid the finance department of the healthcare organisation.
About Pacific Knowledge Systems
PKS provides a proprietary subscription based Clinical Decision Support system (CDS) called “RippleDown” that automates the human decision-making process within healthcare organisations.
PKS’ customers include laboratories, hospitals and other healthcare organisations. PKS has an experienced management team and a Board with extensive healthcare and technology experience.
PKS is a profitable business operating in the large and growing healthcare IT solutions market.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
